Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Milestone approval lifts Illumina's NGS from research into clinic

Nature Biotechnology volume 32, pages 111–112 (2014)Cite this article

Subjects

Greg Heath, senior vice president and general manager for diagnostics at Illumina, likens the technology to an “X-ray for the genome.” Illumina customers will be able to probe the genome with unprecedented levels of sensitivity and accuracy to develop novel in vitro diagnostic assays, biomarkers and other analytical tests.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Dublin

    Cormac Sheridan

Authors
  1. Cormac Sheridan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sheridan, C. Milestone approval lifts Illumina's NGS from research into clinic. Nat Biotechnol 32, 111–112 (2014). https://doi.org/10.1038/nbt0214-111

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0214-111

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research